ABSTRACT: Here, we analyzed histological findings and parasite burden in chronic Neospora caninum infection in BALB/c and ICR mice and studied the correlation between lesion severity and parasite load in brain. To obtain a better understanding of the infection, we examined the influence of various host-pathogen factors. Groups of outbred (ICR) and inbred (BALB/c) mice were inoculated using several NC-1 parasite doses (4 ϫ 10 5 , 10 6 , and 5 ϫ 10 6 tachyzoites), inoculation routes (intraperitoneal and subcutaneous), and 3 immunosuppressive treatments (methylprednisolone, cyclophosphamide, and vinblastine). Lesion severity was analyzed in the liver, lung, heart, and brain tissues, and parasite load was measured by real-time polymerase chain reaction in brain tissue. The results indicated more severe cerebral lesions and higher brain parasite burdens in inbred than in outbred mice. Hepatic tissue was the primary lesion site in immunosuppressed ICR mice. We also observed that increased inoculum size was reflected in greater lesion severity and a higher cerebral parasite load. No difference was observed with respect to inoculation route. The study also showed an association between brain parasite burden and severity of cerebral lesions in BALB/c mice.
Neospora caninum is a cyst-forming coccidian parasite closely related to Toxoplasma gondii, which is recognized worldwide as a cause of neuromuscular disease in dogs and abortion in cattle (Dubey and Lindsay, 1996) . Since the discovery of N. caninum in 1988 (Dubey et al., 1988) , most information on the pathogenesis of the disease and the immune response has been derived from laboratory models in which several mouse strains were inoculated experimentally with the parasite (Lindsay and Dubey, 1989b; Lindsay et al., 1995; Khan et al., 1997; Long et al., 1998; Baszler, Long et al., 1999; Eperon et al., 1999; Shibahara et al., 1999) . Inbred BALB/c mice can develop clinical neosporosis and have been used extensively as a laboratory model of N. caninum infection. Outbred mice are relatively resistant to N. caninum infection; nonetheless, they have been used in a pregnant mouse model Quinn et al., 2002) and to produce tissue cysts in brain (McGuire et al., 1997) or to isolate the parasite from tissues of naturally infected animals after immunosuppressive drug treatment (Dubey et al., 1998; Canada et al., 2002) . It has been suggested that parasite isolate, immunosuppressive drug treatment, dose, and route of inoculation are important factors (Innes et al., 2000) that can produce variability in resistance to infection or determine the development of subclinical or fatal disease in mice.
Parasite load in host tissue is also an important component of disease development (Long et al., 1998) . Despite many reports on murine experimental infection, only limited information is available on parasite burden in tissues (Long et al., 1998; Baszler, Long et al., 1999; Liddell et al., 1999) . Parasite presence has traditionally been demonstrated by visual enumeration of organisms, although this method is relatively insensitive (Baszler, Lawrence et al., 1999) , time-consuming, subjective, and requires experience. We recently described a quantitative polymerase chain reaction (PCR) for quantification of N. caninum in tissue samples (Collantes-Fernández et al., 2002) , which may be useful for studying parasite load and establishing a correlation between lesion severity and parasite burden.
Here, we analyzed lesion development in several organs (liver, lung, heart, and brain) and brain parasite burden in chronic N. caninum infection of inbred and outbred mice, studying various infective doses, inoculation routes, and immunosuppressive treatments. In addition, we examined the correlation between brain parasite burden and lesion severity. Characterization of parasite load and histological findings are important in the development of future strategies for the prevention and treatment of N. caninum infection.
MATERIALS AND METHODS

Mice
Female ICR (outbred) and BALB/c (inbred) mice weighing 25-30 g were obtained from a commercial supplier (Harlan Ibérica, Barcelona, Spain). They were free of common viral, parasitic, and bacterial pathogens according to routine screening results from the supplier. Mice received rodent food and water ad lib. and were maintained in an environmentally controlled room with 12:12 hr light-dark cycles.
Experimental design and samples
Immunosuppressive drug regimens and infectious dose sizes were selected to establish a chronic infection. Mouse strains, inoculum size, immunosuppressive treatments, inoculation routes, and number of animals used are shown in Table I . Briefly, ICR mice were immunosuppressed using 1 of 3 treatments (methylprednisolone acetate, MPA; cyclophosphamide, Cy; and vinblastine, VLB), then inoculated intraperitoneally (i.p.) or subcutaneously (s.c.) using 4 ϫ 10 5 or 10 6 NC-1 tachyzoites. Groups of BALB/c mice were also inoculated i.p. or s.c. with 10 6 or 5 ϫ 10 6 NC-1 tachyzoites. Control groups of BALB/c, ICR, and immunosuppressed ICR mice were inoculated i.p. with 200 l of phosphate-buffered saline (PBS). Nonimmunosuppressed control ICR groups were inoculated i.p. or s.c. with 4 ϫ 10 5 NC-1 tachyzoites. All animals were inoculated at 6 wk of age and killed 8 wk postinfection (PI) using CO 2 gas. Brain tissue was recovered with stringent aseptic precautions to avoid crosscontamination and 1 hemisphere frozen at Ϫ80 C. The other brain hemisphere, heart, liver, and lung were fixed in 10% neutral buffered formalin solution for processing by routine histological methods and were stained with hematoxylin and eosin (HE). Animals were monitored daily for the presence of clinical signs; moribund animals were killed and samples collected.
Parasites and preparation of inoculate
Neospora caninum tachyzoites (NC-1 isolate) were maintained by continuous passage in Vero cell culture, using standard procedures, as described (Lindsay and Dubey, 1989a) . Parasites were harvested from tissue culture, and viability was determined by trypan blue exclusion, followed by counting 3 aliquots in a Neubauer chamber. For inoculation, organisms were adjusted to the appropriate concentration (200 l/ mouse). Tachyzoites for DNA extraction were washed 3 times in sterile PBS, pH 7.4, and separated from host cell debris by passing the mixture through a 25-gauge needle after passage through a 5-m polycarbonate filter. NC-1 purified tachyzoites were pelleted and stored at Ϫ80 C.
Histopathological analysis
Tissues fixed in 10% neutral formalin and dehydrated through graded alcohols were paraffin embedded, sectioned, and stained with HE. Multiple sections of different regions from the brain, heart, liver, and lung were examined. Analysis was based on the observation of lesions characteristic of or consistent with N. caninum infection (Lindsay and Dubey, 1989b ), according to the following pattern: brain, meningitis, glial nodules, areas of mineralization, granulomas, and cuffing of blood vessels; heart, myocarditis; liver, portal activity and microgranulomas; and lung, interstitial pneumonia. Each lesion was graded according to severity of inflammation (nil ϭ 0, slight ϭ 1, mild ϭ 2, moderate ϭ 3, and severe ϭ 4). The mean of these values was determined for each animal, and a median lesion score corresponding to each group and organ was represented.
DNA extraction
Genomic DNA was extracted from 10 7 tachyzoites of N. caninum NC-1 isolate as positive control and from 20 mg of murine brain tissue using the Genomic-Prep cell and tissue DNA isolation kit (Amersham Biosciences, Uppsala, Sweden) following the manufacturer's instructions. Animal tissue samples were pretreated with proteinase K (100 g/ml) (Sigma Chemical Co., St. Louis, Missouri) at 55 C for 3 hr to overnight.
Evaluation of brain parasite burden
Parasite DNA in brain tissue was quantified by real-time PCR using the double-stranded DNA-binding dye SYBR Green I. We used primer pairs from the N. caninum Nc5 sequence to quantify the parasite and primers from the 28S ribosomal RNA (rRNA) gene to quantify host DNA. Reactions for the N. caninum Nc5 sequence and the 28S rRNA gene were performed in separate tubes, as reported previously (Collantes-Fernández et al., 2002 ). All samples were tested in duplicate; amplification, data acquisition, and data analysis were carried out in the ABI 7700 Prism Sequence Detector machine (Applied Biosystems, Foster City, California). Neospora caninum number was calculated by interpolation of the corresponding Ct values (cycle threshold: the fractional cycle number reflecting a positive PCR result) on a standard curve from DNA equivalent to 10 Ϫ1 to 10 4 tachyzoites. DNA amount per sample was normalized by quantification of the 28S rRNA gene, and a standard curve was generated with 5-fold serial dilutions of mouse brain DNA quantified by UV spectrophotometry. Data were analyzed using Sequence Detection System Software v.1.6 (Applied Biosystems) and results exported to Microsoft Excel for statistical analysis. After amplification for N. caninum Nc5 sequence, PCR product melting curves were acquired by a stepwise temperature increase from 55 to 95 C for 20 min. Data were analyzed using Dissociation Curves 1.0 f. software (Applied Biosystems).
Data analysis
Factors and groups were compared as described (Table II) , following the indications of Morrison (2002) . The nonparametric Mann-Whitney U-test was used to analyze inoculum size and mouse strain factors, and the Bonferroni correction of error rate was used for the inoculation route factor. The nonparametric Kruskal-Wallis test was used to analyze the immunosuppressive treatment factor. When statistically significant differences were found, a nonparametric multiple comparison test was applied to examine all possible pairwise comparisons. A value of P Ͻ 0.05/[k ϫ (k Ϫ 1)/2] was considered statistically significant, with k corresponding to group number. Infected groups were compared with their respective noninfected controls, and ICR immunosuppressed infected groups were compared with ICR infected, but not immunosuppressed, groups. A Mann-Whitney U-test was used to compare parasite numbers in brain samples from mice with and without compatible lesions. Finally, to evaluate whether brain lesion severity correlated with brain parasite burden, regression analysis was performed to determine the Pearson correlation coefficient r; the strength of the relationship was expressed as r 2 . A value of P Ͻ 0.05 was considered statistically significant. Statistical analysis was carried out using SAS software v.8.2 (SAS Institute, Cary, North Carolina) and Statistica software v.5.0 (StatSoft, Tulsa, Oklahoma).
RESULTS
Mortality and clinical signs of disease
Mortality and clinical signs of disease (rough hair coats, inactivity, and pelvic limb weakness) were observed in very few animals from week 5 to week 8 PI. One mouse each from groups 5 and 11 died on days 40 and 53 PI, respectively, and 2 mice (group 9) on days 50 and 53 PI. Clinical signs were apparent in 3 mice from group 4 (week 5 PI) and 1 mouse each from groups 10 and 11 (week 7 PI). The other infected and control mice remained clinically normal during the 8-wk study period. 
Lesion development in experimentally inoculated mice
Although clinical evidence of infection appeared in a few mice, microscopic lesions were found in a larger number of animals, with groups 1-4 (MPA-ICR) and 9-12 (BALB/c) showing higher lesion frequencies in the liver and brain (Table  III) . Median inflammation scores ranged from nil to slight in the groups inoculated with the parasite (groups 1-14), with the exception of the brain, where some BALB/c mice showed more severe lesions (mean grade ϭ 1-2). The lung and heart were the least affected organs.
Statistical analyses revealed differences in lesion severity when the different factors were compared. Inflammation was more severe in groups inoculated with a higher parasite dose; significant differences were found in the brain of MPA-ICR mice (2 vs. 4; P Ͻ 0.05, Mann-Whitney U-test) and in the liver of MPA-ICR (1 vs. 3; P Ͻ 0.001) and BALB/c mice (10 vs. 12; P Ͻ 0.05). A similar tendency was observed in the other organs studied, although this was not significant. Severity varied according to mouse strain, depending on the organ tested. The liver and lung were more severely affected in ICR than in BALB/c mice (liver ϭ 1 vs. 11; P Ͻ 0.05; 2 vs. 12; P Ͻ 0.01; lung ϭ 2 vs. 12; P Ͻ 0.05). Cerebral lesions were significantly more severe in the inbred strain (1 vs. 11; P Ͻ 0.05). In contrast, no significant difference was found in mice that received immunosuppressive treatment (P Ͼ 0.05, Kruskal-Wallis test). Mice immunosuppressed with MPA nonetheless showed more severe lesions in brain than mice given Cy or VLB. The inoculation route did not affect infection outcome. Statistically significant differences in lesion severity were observed when infected groups were compared with their respective noninfected controls, specifically in the liver (groups 1, 2, 4, 5, 6, and 10) and brain (groups 2, 9, 10, and 12). ICR immunosuppressed infected groups showed significantly more severe lesions in the liver than infected, nonimmunosuppressed groups (groups 4-6).
Neospora caninum tachyzoites were rarely detected in the distinct organs in conventional HE-stained histological preparations. Free groups of parasites were only observed in 1 BALB/c mouse brain (group 10). Tissue cyst-like structures were seen in the brain in 3 BALB/c mice (groups 9-11). No lesion or parasite stage was observed in the organs tested from the 3 PBS-injected control groups.
Assessment of parasite load in brain tissue
Final results are expressed as number of parasites per microgram of host DNA. In this system, each sample was normalized on the basis of mouse DNA content, and the result is independent of the quantity of DNA tested. To ensure that N. caninum DNA amplification was not inhibited, the 28S rRNA gene was used to exclude false negatives. Melting curve analysis detected a single product with a melting temperature of 79.0 C in samples containing N. caninum DNA.
The parasite was detected in the brain in a larger number of animals corresponding to MPA-ICR (groups 1-4) and BALB/c (groups 9-12) mice (Fig. 1) . When samples were analyzed statistically, an increase in parasite burden correlated with increased parasite dose and was significantly higher in BALB/c mice inoculated with 5 ϫ 10 6 than in mice inoculated with 10 6 tachyzoites (9 vs. 11; P Ͻ 0.05, Mann-Whitney U-test). In contrast, an increase in the infectious dose of N. caninum in ICR mice had only a minor effect on parasite DNA levels.
Comparison of the 2 strains showed that inoculated BALB/c mice had a higher brain parasite load than ICR mice, although this was not significant (P Ͼ 0.05). Significant differences were found in mice that received immunosuppressive treatment (P Ͻ 0.05, Kruskal-Wallis test). Using a multiple comparison test to determine which groups differed from each other, significantly higher parasite burdens were found in mice immunosuppressed with MPA than with Cy (3 vs. 5; P Ͻ 0.01). No significant difference was detected between inoculation routes. No parasite DNA was detected in brains of control mice (groups 13-17).
In histological examination, we observed a clear relationship between brain parasite burden and the presence of parasite tissue cyst-like structures. When the 3 BALB/c mice with tissue cyst-like structures were analyzed by real-time PCR, 2 showed a high brain parasite burden compared with their corresponding median group (144.8 vs. 3.1 parasites/g host DNA and 109.6 vs. 0.4 parasites/g host DNA).
Association between brain lesion and parasite burden
We analyzed whether parasite burden was significantly higher in brain samples with lesions than in samples with no detectable lesion. Data showed a significantly higher parasite number per microgram in brain samples with lesions (P Ͻ 0.01, Mann-Whitney U-test). Regression analyses to establish whether brain lesion severity correlated with brain parasite burden showed that the strength of the relationship was low in ICR mice (r 2 ϭ 0.01; P Ͼ 0.05) and moderate in BALB/c mice (r 2 ϭ 0.6; P Ͻ 0.0001).
DISCUSSION
In this study, we characterized lesions and brain parasite burden in chronic N. caninum infection in outbred and inbred mouse models. We monitored the parasite in brain, which is the organ most commonly involved in chronic infection, both in the definitive canine host and in a broad range of intermediate hosts (Buxton et al., 2002) including the murine experimental model Long et al., 1998) . The development of chronic N. caninum infection models may be of use for understanding parasite persistence in the central nervous system (CNS) and for studying factors that influence parasite recrudescence.
In most cases studied here, the animals showed no clinical manifestation and presented a low number of parasites and slight brain lesions. The inbred and outbred mice used are known to show different disease susceptibilities in murine N. caninum infection because BALB/c mice are more sensitive to N. caninum infection than ICR mice . Treatment of ICR mice with immunosuppressive agents is necessary to overcome this natural resistance. Cerebral lesions were more reproducible, and higher brain parasite burdens were observed in inbred than in outbred mice, indicating that BALB/ c mice were more susceptible to chronic infection than ICR mice, even when the latter were immunosuppressed. Other studies have examined susceptibility to N. caninum infection in various murine strains. Khan et al. (1997) found no difference in susceptibility between inbred (A/J, C57BL/6, BALB/c) and outbred mouse strains (CD-1) during the first 2 wk PI. Mice had nominal infection with no clinical sign and rare inflammation with few identifiable parasites in brain; other organs were unaffected. Another study compared the relative resistance of inbred strains (BALB/c, C57BL/6, B10.D2) at 6 wk PI, showing that BALB/c and C57BL/6 were more susceptible to cerebral lesion development than B10.D2 mice (Long et al., 1998) . McGuire et al. (1997) used MPA-treated ICR and BALB/c mice inoculated with NC-2 and NC-Liverpool isolates to produce tissue cysts. The largest numbers of tissue cysts were observed in MPA-immunosuppressed ICR inoculated with NCLiverpool. In our study, NC-1 induced development of a small number of tissue cysts only in BALB/c mice, revealing notable differences in the capacity for tissue cyst formation by different parasite isolates. Outbred mice have also been treated with immunosuppressive agents to isolate the parasite (Dubey et al., 1998; Canada et al., 2002) . In this study, we evaluated the effect of 3 commonly used immunosuppressive drugs, including corticoids (MPA) and cytotoxic agents (Cy and VLB), in ICR mice. To establish chronic infection with low mortality, dosage was chosen to induce low-level immunosuppression. Infection outcome was affected in part by administration of immunosuppressive therapy, and hepatic tissue damage was the main lesion produced. Our results show that MPA-immunosuppressed mice had more severe lesions and a higher parasite burden in brain than Cy-or VLB-immunosuppressed mice. In all immunosuppressed groups, however, cerebral inflammation and brain parasite numbers were minimal, indicating acute infection that was probably controlled by the immune system in the long term. These results may be due to the cytotoxic and antiproliferative effects of Cy and VLB, or that the doses of Cy and VLB administered might have a mild effect on establishment of chronic infection. Given at a low dose, MPA was more effective at reproducing chronic N. caninum infection, as reported (Lindsay and Dubey, 1989b) .
Mice were inoculated with different doses of N. caninum, and the larger inocula were correlated with lesion severity. Increased inoculum size was reflected in a higher cerebral parasite level in BALB/c mice, suggesting that the mouse's ability to control the expansion of parasites appears to depend on initial infection dose. These findings concur with a previous study (Long et al., 1998) showing that a significant increase in lesion number was associated with increased inoculum size. Gottstein et al. (2001) observed an increase in parasite DNA detectability by PCR as well as severe symptoms in mice inoculated with the higher infective dose. Our study also demonstrates association between CNS lesion severity and brain parasite burden, only in BALB/c mice. This correlation was not found for immunosuppressed ICR mice, which had a low cerebral parasite load. Low parasite numbers were detected in brain tissues with an absence of or with only slight lesions. These results suggest that parasite presence in the brain contributes to lesion development, although this appears to require a significant number of organisms.
This study provides information on the infection response of mice inoculated i.p. and s.c. After i.p. inoculation, parasites would presumably be present first in the peritoneal cavity and infect all associated organs, leading to rapid, strong exposure of cultured tachyzoites to antigen-presenting cells in the spleen and peritoneum. When introduced by the s.c. route, parasites could migrate to local lymph nodes, and antigen would be processed in a different manner. Earlier results concerning inoculation routes are nonetheless controversial. A recent study of a pregnant mouse model for N. caninum infection (Quinn et al., 2002 ) reported brain lesions in mice infected s.c. and i.p., although s.c. injection had more severe effects. This observation concurs with a study showing that mice inoculated i.p. did not produce clinical signs of disease or brain lesions (Atkinson et al., 1999) . Another study showed that mice inoculated i.p. died earlier in the infection than mice inoculated s.c., before pneumonia, myositis, or encephalitis developed (Lindsay and Dubey, 1990) . Our results indicated no difference with respect to the inoculation route used.
Parasite burden has proved to be a good indicator of parasite pathogenicity, and the real-time PCR is a simple, sensitive assay for quantifying parasite load in host tissues, revealing a clear correlation between lesion and parasite burden. We consider this method a valuable tool for the study of N. caninum pathogenesis in murine models.
